Dear Avon and Wiltshire Mental Health Partnership NHS Trust,

I would like to request information for the below questions.

The purpose of these questions is to understand the variability of treatment within your trust and in context to the rest of the country.

Q1. How many patients has your trust treated (for any disease) in the last 6 months (or the latest 6 months data you have available) with the following treatments:

• Revolade (eltrombopag)
• Nplate (romiplostim)
• Doptelet (avatrombopag)
• Tavlesse (fostamatinib)

Q2. In the last 6 months (or the latest 6 months data you have available), how many patients has your trust treated for immune thrombocytopenia (ITP)?

Q3. Of the patients treated for immune thrombocytopenia (ITP) in the last 6 months (or the latest 6 months data you have available), how many were treated with:

rituximab
mycophenolate mofetil
surgery (splenectomy)

Q4. Does your trust participate in any ongoing clinical trials for immune thrombocytopenia (ITP)? If so, can you please provide the name of each trial along with the number of patients taking part?

Thank you for taking the time to answer these questions and I look forward to your response.

Yours faithfully,

Oliver Caswell

FREEDOMOFINFORMATION (AVON AND WILTSHIRE MENTAL HEALTH PARTNERSHIP NHS TRUST), Avon and Wiltshire Mental Health Partnership NHS Trust

Dear Oliver

We are a mental health Trust

Yours sincerely

Freedom of Information Team

show quoted sections